DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 1 filers reported holding DERMA SCIENCES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $128,000 | +100.0% | 24,514 | +78.8% | 0.00% | – |
| Q3 2016 | $64,000 | +700.0% | 13,708 | +571.0% | 0.00% | – |
| Q2 2016 | $8,000 | -65.2% | 2,043 | -72.2% | 0.00% | – |
| Q1 2016 | $23,000 | -58.2% | 7,352 | -37.9% | 0.00% | – |
| Q4 2015 | $55,000 | -33.7% | 11,837 | -32.9% | 0.00% | – |
| Q3 2015 | $83,000 | -48.4% | 17,649 | -21.5% | 0.00% | – |
| Q2 2015 | $161,000 | +78.9% | 22,490 | +111.7% | 0.00% | – |
| Q1 2015 | $90,000 | -4.3% | 10,625 | +4.5% | 0.00% | – |
| Q4 2014 | $94,000 | -35.6% | 10,170 | -41.7% | 0.00% | – |
| Q3 2014 | $146,000 | -1.4% | 17,447 | +35.5% | 0.00% | – |
| Q2 2014 | $148,000 | +23.3% | 12,877 | +36.4% | 0.00% | – |
| Q1 2014 | $120,000 | +757.1% | 9,441 | +655.9% | 0.00% | – |
| Q4 2013 | $14,000 | – | 1,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
| DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
| Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
| Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
| Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
| HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
| J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
| Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
| Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |